Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

The France Foundation

Clearing the Air on Chuck’s Asthma

Access Activity

Overview / Abstract:

LEARNING OBJECTIVES
Upon completion of the activity, participants should be able to:

Perform a thorough assessment of asthma severity and control in day-to-day practice
Explain how mechanisms of action of new/emerging type 2 inflammation-directed treatments address the underlying immunology of asthma
Select appropriate type 2 inflammation-targeted therapies on the basis of safety and efficacy data, and phenotype

Expiration

Jun 30, 2020

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physical Therapy CE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE, Respiratory Therapy CE

Format

Webinar / Webcast / Video

Credits / Hours

0.25

Accreditation

ACCME

Presenters / Authors / Faculty

James Donohue, MD
Professor of Medicine
Pulmonary Disease and Critical Care Medicine
UNC School of Medicine
Chapel Hill, NC

Sponsors / Supporters / Grant Providers

This activity is supported by independent educational grants from Actelion Pharmaceuticals US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Genentech and Mallinckrodt Pharmaceuticals.

Keywords / Search Terms

The France Foundation, Asthma, Free CE, CME

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.